Celebrating RNA: The Unsung Hero of Molecular Biology 🧬

August 1st marked RNA Day, a moment to celebrate one of science’s most elegant and essential molecules. While DNA often steals the spotlight, it's RNA that rolls up its sleeves and gets to work — transcribing, translating, and even starring in next-generation vaccines. At Fluorobiotech, where mRNA and its molecular...

Fluorobiotech’s Mission: Decentralizing Enzyme Manufacturing for a More Equitable Biotech Future

Fluorobiotech is on a mission to redefine access to essential biotechnology infrastructure by transforming how critical enzymes are produced, supplied, and scaled. With a focus on innovation, affordability, and autonomy, the company is empowering underserved markets and industries through next-generation recombinant protein technologies that decentralize enzyme manufacturing and build lasting...

Fluorobiotech Showcases Local Biomanufacturing Innovation at WHO / MPP Global Partners Meeting

Fluorobiotech was honored to present at the Global Partners Meeting of the WHO / Medicines Patent Pool (MPP) mRNA Vaccine Technology Transfer Program, a landmark event that brought together manufacturers, policymakers, and researchers from over 15 countries committed to building mRNA vaccine manufacturing capacity in low- and middle-income countries (LMICs)....

Fluorobiotech Takes the African Tech Stage at VivaTech 2025 in Paris

Fluorobiotech proudly represented African innovation on the global stage as Chief Operating Officer, Dr. Ross Rayne Vermeulen delivered a pitch at VivaTech 2025, one of the world’s leading events for technology and innovation. Selected to present on the African Tech Stage, Vermeulen shared Fluorobiotech’s ambitious mission to transform Africa into...

Fluorobiotech Selected as Finalist in AUDA-NEPAD ‘Home Grown Solutions’ Accelerator for Pandemic Resilience

Fluorobiotech is proud to announce its selection as a finalist in the prestigious 5th Cohort of the AUDA-NEPAD ‘Home Grown Solutions’ Accelerator for Pandemic Resilience. The program, which aims to strengthen Africa’s ability to respond to pandemics by supporting high-impact health innovations, received more than 200 written applications from 37...

Fluorobiotech celebrates recent grant Award

Fluorobiotech is proud to announce that, in collaboration with the Stellenbosch University Biofoundry, we have been awarded a landmark € 350 thousand grant to help expand local vaccine production capabilities by advancing local production of critical enzymes for mRNA vaccine manufacturing. Our mission: to build a self-reliant, scalable, and sustainable...

Fluorobiotech raising the Bar at Stellenbosch – Launch Lab CERI BIO is Here

In partnership with Stellenbosch University, Fluorobiotech proudly announces the completion of Launch Lab CERI Bio—an innovation hub designed to accelerate early-stage South African biotech startups addressing global challenges. Why This Lab Matters Commercialising biotech innovation requires four pillars: a breakthrough idea, a tenacious founding team, funding, and a compliant physical...

Welcoming the next generation of biotech leaders

This past Friday, our CEO, Dr. Du Preez van Staden, and Junior Production Scientist, Nsizwa Biyela, had the privilege of engaging with CSSFF-SAMRC interns at an industry networking session. The event brought together representatives from 10 companies, each showcasing their work and impact within the South African bioeconomy—offering valuable insights...